BUOY

Live / Applied — Statement of use — processing complete, to examiner (as of 10 Sept 2026)

What this means for you

Not registered yet, but its 17 Nov 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90323594
Mark type
Stylized text
Filed
17 Nov 2020
Published for opposition
07 Dec 2021
Attorney of record
DARREN M. GELIEBTER

Goods and services

  • Class 035 — Advertising and business services: Electronic data collection, data processing, and data analysis, all of the foregoing for business purposes, namely, for use in connection with the collection, screening, testing, transport, distribution, and storage of human blood plasma; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers
  • Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for operating, administering and managing blood plasma collection and donation centers, and the associated compensation and incentive reward programs administered therewith; Software development for use in connection with operating, administering and managing of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Mobile application software development for use in connection with operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Application service provider featuring application programming interface (API) software and on-line, non-downloadable software development tools for use in operating, administering and managing of blood plasma donation and collection centers and the associated compensation and incentive reward programs administered therewith; platform as a service (PAAS) featuring application programming interface (API) software and on-line, non-downloadable software development tools for operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Consultancy relating to computer software for the operation, administration, and management of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Software subscription, namely, rental of computer software for use in connection with operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; leasing and customizing white label software platform for use by blood plasma donation and collection centers; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers
  • Class 045 — Legal and security services: Licensing of software for the operation, administration, and management of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; white label software services, namely, licensing of computer software platform to blood plasma donation and collection centers for use in association with their own branding; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers

Owner

Prosecution history

  • 10 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 08 Sept 2026 — USE AMENDMENT FILED
  • 08 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
  • 17 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 16 Jul 2026 — SOU EXTENSION 5 GRANTED
  • 05 Mar 2026 — SOU EXTENSION 5 FILED
  • 16 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
  • 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 05 Sept 2025 — SOU EXTENSION 4 GRANTED
  • 05 Sept 2025 — SOU EXTENSION 4 FILED
  • 05 Sept 2025 — SOU TEAS EXTENSION RECEIVED
  • 15 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Mar 2025 — SOU EXTENSION 3 GRANTED
  • 03 Mar 2025 — SOU EXTENSION 3 FILED

View this trademark record on Marksy